China Feihe Limited Stocks

HK$ 3.4Last Updated 15.04.2026

Issuer Rating

6/7
Performance

Strong

Risk

Limited

Recommendation

Buy

Market Cap

HK$ 3.88B

Buy
Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
HK$ 3.4
Key Takeaways

Risk factor

Good trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Excellent dividends

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

China Feihe Limited, an investment holding company, produces and sells infant milk formula products in Mainland China and the United States. The company offers a range of raw milk, adult milk powders, liquid milk products and health care products, as well as soybean powder and goat milk powder. It is also involved in the retail of vitamins, minerals, herbs, and other nutritional supplements. The company sells its products through distributors; and e-commerce platforms, such as Tmall, JD.com, and Suning.com, as well as through its website and mobile application, including WeChat. As of December 31, 2021, it operated a distribution network of approximately 2,000 offline customers with 110,000 retail points of sale. China Feihe Limited was founded in 1962 and is headquartered in Beijing, the People's Republic of China.

Company Valuation

Undervalued
6/7

From both historical and forecast perspectives, the stock is underpriced compared to similar stocks. In particular, the stock is underpriced on P/E, 'cheap' on EV/EBITDA,

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Favourable
6/7

The average target price of 6186.HK is 5.7 and suggests 66% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to incr

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis
X-channel

Buy

Sell

0 more stocks